Immunotec Announces Completion of its International Convention in Mexico City

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry (the "Company") today announces the completion of its
International Convention held from February 20 to 22, 2014 at the Expo Bancomer
Convention Center in Santa Fe, Mexico. Under the theme One Vision, One Team,
nearly 1,500 independent Consultants participated in celebrating the Immunotec
heritage of developing innovative products while being recognized for their
accomplishments over the past year.


"This event was a success surpassing previous Convention attendee counts and a
testimony of our performance in Mexico," said Mr. Charles L. Orr, Chief
Executive Officer." This platform also launched our new plans for 2014. The new
programs are designed to support our Field in achieving future growth as we are
preparing to leverage the content and excitement of this Convention on a road
tour in many cities starting March 15th in Montreal, Toronto, Orlando, Los
Angeles and more to come."


"Many of our independent Consultants experienced growth in building their
businesses during 2013. This has enabled them to advance in rank while
developing their businesses across our network and markets," said JP Trottier,
Immunotec's Vice-President of Business Development. "The 2014 Trip Incentive
this coming November was launched and everybody committed to reach new heights
and qualify to attend."


About Immunotec Inc.

Immunotec Inc. is dedicated to making a positive difference in people's
lifestyle every day by offering research-driven nutritional products through its
network of Independent Consultants worldwide. Immunotec's strength comes from
its culture that emphasizes teamwork and entrepreneurial leadership by
employees, consultants and research collaborators.


Headquartered with manufacturing facilities near Montreal, Canada, Immunotec
Consultants generate nearly $55.0 Million in annual revenues. Please visit us at
www.immunotec.com for additional information.


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this
release.


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Patrick Montpetit CPA, CA, CF
Vice-President and Chief Financial Officer
Immunotec Inc.
[phone]